Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you you could cut past all that. We did.

Learn More

News Details

May 08, 2017

Dohmen announces new Vice President, Contracting and Payer Access, DLSS

Dohmen has appointed Brian Davis as its new Vice President of Contracting and Payer Access for orphan drug manufacturers for Dohmen Life Science Services. With 15 years of experience in managed care contracting, he has held roles leading both contracting and compliance departments. He’s also a pharmacist and has an extensive background in public policy and professional regulation.

In this new role, Davis is ensuring that DLSS has the right strategic relationships with payers. “Payer contracting is very critical and we prioritize our payer relationships to make sure our clients and their patients get the support they need,” says Davis.

“Everything comes down to the speed and accuracy of reimbursements,” he adds. “Each client drug or therapy has a unique payer model, but no matter if it is medically or pharmaceutically benefited, we’re prepared to help our clients navigate participating agreements quickly and effectively.” 

Davis has a Masters of Science in Pharmacy from the University of Florida as well as a bachelor’s degree in Pharmacy from St. Louis College.